Malin Corporation | MLC - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
ALKERMES USD 167.54M 1.08M 2026-06
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Eurofins Scientific SE EUR 172.35M 5.55M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Lonza CHF 68.64M 0 2025-12
Malin Corporation EUR 200K 0 2024-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 262.61M 40K 2026-06
Ovoca Bio EUR 29.49M 0 2025-12
Revvity USD 111.63M 174K 2026-06
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Viatris USD 1.16B 9.19M 2026-06
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03